ALLEN R. NISSENSON, M.D.; MARVIN J. RAPAPORT, M.D.; ROBERT G. NARINS, M.D.
To the editor: We agree with Halevy and colleagues (1) that further controlled trials are needed before we can conclusively determine the role of hemodialysis or peritoneal dialysis in the treatment of psoriasis. We must take strong exception to some of their statements, however.
Generalized psoriatic exfoliative dermatitis is an uncommon form of psoriasis often refractory to conventional therapy. By studying such patients, we may indeed have selected just those who would respond to no form of treatment. On the other hand, we felt that a technique such as hemodialysis, with serious potential side effects, should be attempted only in
NISSENSON AR, RAPAPORT MJ, NARINS RG. Dialysis and Psoriasis. Ann Intern Med. ;92:709–710. doi: 10.7326/0003-4819-92-5-709_2
Download citation file:
Published: Ann Intern Med. 1980;92(5):709-710.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use